Clinical Trial Update: Clinical Performance Evaluation of the Hativ P30 [NA]

View source ↗

Summary

A clinical performance evaluation trial for the Hativ P30 targeting arrhythmia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia

Drugs mentioned

• Hativ P30

Snippet

Sponsor: VUNO Inc. | Conditions: Arrhythmia | NA | Status: WITHDRAWN